SID 2026Late-breaking abstract LB1204
SPECTREM: Guselkumab lowers disease-related serum cytokines in low BSA, moderate psoriasis with high-impact sites
Chen E, Cooper P, Kwatra S, Cho R, Han G, Farberg A, Alkousakis T, Panchakshari R
SID Annual Meeting 2026Late-breaking abstractsChicago, 13–16 May 2026 · published in JID 21 Jul 2026
Topics: PsoriasisSkin biologyBiologics
Abstract
The abstract’s text is on the JID website.
DOI 10.1016/j.jid.2026.06.1235 · Not in PubMed: details from Crossref